Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

News Daily News EuroPCR 2025

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

Michael O'Riordan

May 28, 2025

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

News Features

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Michael O'Riordan

January 06, 2023

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

September 23, 2022

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

News Conference News TCT 2022

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

September 19, 2022

Making Sense of MI: EXCEL and SYNTAX Tackle Event Definitions

News Daily News

Making Sense of MI: EXCEL and SYNTAX Tackle Event Definitions

Michael O'Riordan

September 28, 2020

FDA Expands TAVR Indication to Low-Risk Patients

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

Michael O'Riordan

August 16, 2019

New TAVR NCD a ‘Missed Opportunity’ to Align SAVR, TAVR Quality

News Daily News

New TAVR NCD a ‘Missed Opportunity’ to Align SAVR, TAVR Quality

June 27, 2019

TAVR’s Two-Surgeon Sign-off Rule Must Go, Experts Say

News Daily News

TAVR’s Two-Surgeon Sign-off Rule Must Go, Experts Say

July 23, 2018

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

News Conference News TCT 2017

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Yael L. Maxwell

November 09, 2017

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Daily News

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

July 07, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.